Concepedia

Theodoros Karantanos

TK

Statistics

Publications

38

Citations

1.7K

H-Index

21

Active since

2009

Affiliations

Johns Hopkins University(Current)

Sidney Kimmel Comprehensive Cancer Center

National and Kapodistrian University of Athens

Johns Hopkins Medicine

The University of Texas MD Anderson Cancer Center

Theodoros Karantanos is an author at Johns Hopkins University specializing in oncology, medicine, and molecular oncology.

Publications per year

2009–2025

38

Publications

38

Androgen receptor inhibitor–induced “BRCAness” and PARP inhibition are synthetically lethal for castration-resistant prostate cancer

Likun Li, Styliani Karanika, Guang Yang et al. · Science Signaling · 2017 · 304 citations

Medicine, Oncology, Pharmacology +17

Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion

Lisa M. Rooper, Theodoros Karantanos, Yi Ning et al. · The American Journal of Surgical Pathology · 2018 · 118 citations

Medicine, Oncology, Oral Pathology +17

Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling

Styliani Karanika, Theodoros Karantanos, Likun Li et al. · Cell Reports · 2017 · 106 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Current insights in to the pathophysiology of Irritable Bowel Syndrome

Theodoros Karantanos, Theofano Markoutsaki, Maria Gazouli et al. · Gut Pathogens · 2010 · 96 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Targeting Poly(ADP-Ribose) Polymerase and the c-Myb–Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer

Likun Li, Wenjun Chang, Guang Yang et al. · Science Signaling · 2014 · 87 citations

Life Sciences, Molecular Biology, Oncology +12

1–5 of 38